Dieckmann, G. Et Al. 2021. Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain.. The ocular surface , vol.20 , 33-38.

Dieckmann, G., Ozmen, M. C., Cox, S. M., Engert, R. C., & Hamrah, P., (2021). Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain.. The ocular surface , vol.20, 33-38.

Dieckmann, Gabriela Et Al. "Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain.," The ocular surface , vol.20, 33-38, 2021

Dieckmann, Gabriela Et Al. "Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain.." The ocular surface , vol.20, pp.33-38, 2021

Dieckmann, G. Et Al. (2021) . "Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain.." The ocular surface , vol.20, pp.33-38.

@article{article, author={Gabriela Dieckmann Et Al. }, title={Low-dose naltrexone is effective and well-tolerated for modulating symptoms in patients with neuropathic corneal pain.}, journal={The ocular surface}, year=2021, pages={33-38} }